6 August 2026

FDA Pharmaceuticals TGA

TGA reviews avacopan as new data submitted to FDA

9 July 2026

ANCA-associated vasculitis FDA Pharmaceuticals

Avacopan trial retracted as regulators diverge

9 July 2026

ANCA-associated vasculitis Pharmaceuticals

CSL issues open letter as EU moves to revoke avacopan approval

2 April 2026

FDA Pharmaceuticals

FDA liver alert for avacopan

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

21 August 2025

FDA Fibromyalgia

FDA approves first new fibromyalgia therapy in 16 years

10 July 2025

FDA

FDA approves first treatment for life-threatening MAS in Still’s disease patients

1 May 2025

FDA gca2

Giant cell arteritis drug gets FDA and EMA nod

4 December 2024

FDA Pharmaceuticals

Hope for severe Sjögren’s disease

30 November 2023

FDA

CAR-T cell therapy under investigation by FDA

18 August 2022

Hope for new plaque psoriasis treatment

18 December 2020

Biologics Spondyloarthritis

Gilead will not pursue FDA approval of filgonitib for RA

27 August 2020

Analgesics Axial spondyloarthritis Conditions Spondyloarthritis

Filgotinib on hold: FDA delays decision to approve JAKi for RA